IRIS
MICALE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.756
EU - Europa 1.351
AS - Asia 1.032
SA - Sud America 186
AF - Africa 122
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.633
SG - Singapore 545
IT - Italia 419
CN - Cina 375
IE - Irlanda 358
BR - Brasile 169
UA - Ucraina 158
CA - Canada 113
RU - Federazione Russa 104
CI - Costa d'Avorio 80
DE - Germania 60
IN - India 40
SE - Svezia 36
ES - Italia 34
GB - Regno Unito 32
CZ - Repubblica Ceca 28
SN - Senegal 27
FI - Finlandia 24
NL - Olanda 23
KR - Corea 16
FR - Francia 15
TR - Turchia 15
PL - Polonia 11
CH - Svizzera 10
VN - Vietnam 9
AR - Argentina 7
AT - Austria 7
BE - Belgio 7
MX - Messico 7
NG - Nigeria 7
DK - Danimarca 6
GR - Grecia 6
JP - Giappone 6
LB - Libano 6
BD - Bangladesh 4
BG - Bulgaria 4
EU - Europa 4
IQ - Iraq 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
BO - Bolivia 2
PY - Paraguay 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
HK - Hong Kong 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
OM - Oman 1
PK - Pakistan 1
PT - Portogallo 1
SM - San Marino 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.452
Salva come PNG Salva come JPEG
Città #
Santa Clara 752
Dublin 341
Singapore 337
Chandler 300
Jacksonville 234
Chicago 194
Boardman 139
Catania 107
Cambridge 92
Lawrence 92
Andover 90
Nanjing 85
Abidjan 80
Toronto 80
Des Moines 64
Houston 39
Civitanova Marche 35
Nanchang 32
Hebei 30
Hefei 29
Messina 28
Ottawa 28
Dakar 27
Los Angeles 26
Hyderabad 25
Ashburn 24
Rome 24
Saint Petersburg 24
Shenyang 22
Tianjin 22
Changsha 21
Prague 21
Munich 20
Jiaxing 19
Amsterdam 18
San Mateo 18
Wilmington 18
Barcelona 17
Seoul 16
Council Bluffs 15
The Dalles 12
São Paulo 10
Zhengzhou 10
Beijing 9
Florence 9
Jinan 9
New York 9
Lappeenranta 8
Seattle 8
Abuja 7
Atlanta 7
Augusta 7
Belo Horizonte 7
Brussels 7
Dong Ket 7
Moscow 7
Turku 7
Berlin 6
Guangzhou 6
Helsinki 6
Istanbul 6
Madrid 6
Phoenix 6
Redwood City 6
Bremen 5
Foggia 5
Hangzhou 5
London 5
Ningbo 5
San Francisco 5
Tübingen 5
Warsaw 5
Aci Catena 4
Brooklyn 4
Falls Church 4
Grafing 4
Irvine 4
Mumbai 4
Reggio Calabria 4
Rio de Janeiro 4
Shanghai 4
Tokyo 4
Vicenza 4
Bolzano 3
Boston 3
Castelraimondo 3
Columbus 3
Copenhagen 3
Cork 3
Den Haag 3
Dhaka 3
Espoo 3
Frankfurt Am Main 3
Johannesburg 3
Kunming 3
Liberty Lake 3
Manchester 3
Milan 3
Norwalk 3
Philadelphia 3
Totale 3.902
Salva come PNG Salva come JPEG
Nome #
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 93
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 93
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 90
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 86
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 84
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 83
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 82
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 81
Altro che Marijuana i molteplici ruoli delle sostanze cannabinoidi endogene 78
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 78
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 74
Endocannabinoids and neurodegenerative diseases 70
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 70
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 69
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 69
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 69
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 69
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 68
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 67
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 67
Fluoxetine Protects Retinal Ischemic Damage in Mice 66
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 66
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 65
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 65
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 64
Attuali orientamenti terapeutici della malattia di Parkinson 64
Behavioral modifications induced by dietary cholesterol in rats 63
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 62
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 61
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 61
Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid 19-THC in rats 60
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 59
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 58
Therapeutic potential of cannabinoids in schizophrenia 58
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 57
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 56
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 56
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 56
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 55
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 55
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 55
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 55
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 54
Effects of citalopram combined with memantine in forced swimming test in rats 53
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 53
Vitamin D and depression in women: a mini-review 53
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 52
Endocannabinoid system genes regulation in schizophrenia 52
Dual effects of melatonin on barbiturate-induced narcosis in rats 52
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 51
Parkin expression profile in dopamine d3 receptor knock-out mice brains 51
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 51
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 50
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 50
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 50
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 50
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 49
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 49
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 48
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 48
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 48
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 48
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 48
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 48
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 48
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 48
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 47
Dynamic DNA methylation programs persistent adverse effects of early-life stress 47
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 46
Prolonged fear incubation leads to generalized avoidance behavior in mice 46
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 46
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 45
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 45
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 43
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 43
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 42
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 41
Endocannabinoid system and mood disorders: Priming a target for new therapies 41
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 41
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 41
Endocannabinoid system, stress and HPA axis 41
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 41
Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides 40
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 40
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 40
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 39
Leading compounds for the validation of animal models of psychopathology 39
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence 39
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 39
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 38
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 38
Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A 38
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors 37
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 37
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? 35
Cannabidiol and the central nervous system: translating into clinics 35
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice 35
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? 34
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 34
D3 dopamine receptor knockout mice tested in the forced swim test: increased sensitivity to different antidepressant drugs 34
Totale 5.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021381 8 21 46 1 134 9 64 6 21 7 44 20
2021/2022661 91 89 7 23 99 11 95 35 32 2 12 165
2022/20231.050 97 49 12 84 87 186 10 184 262 3 42 34
2023/2024444 31 67 26 32 18 53 4 14 34 17 92 56
2024/20252.327 30 334 127 119 575 352 41 82 162 178 145 182
2025/20263 3 0 0 0 0 0 0 0 0 0 0 0
Totale 5.645